MedTrace Logo

Primary Tumour Response to Induction Chemotherapy in Synchronously Metastasized Colorectal Cancer

NCT05172635 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-12-29

No results posted yet for this study

Summary

We performed a retrospective data analysis of patients with synchronously metastasized colorectal cancer, comparing the histological response on the primary tumour to chemotherapy combined with either vascular endothelial growth factor (VEGF) or epidermal growth factor receptor (EGFR) inhibition.

Conditions

  • Gastrointestinal Neoplasm

Sponsors & Collaborators

  • Klinik Favoriten

    lead OTHER

Principal Investigators

  • Thomas Gruenberger, Prof. Dr. med. · Clinic Favoriten (HPB center)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-01
Primary Completion
2021-02-15
Completion
2021-02-15

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05172635 on ClinicalTrials.gov